These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Correlation of marrow morphology and cytogenetics after blastic transformation in a case with chronic myelocytic leukemia (author's transl)]. Sakurai T, Kudo H, Nagasawa T, Yoda Y, Kawada K. Rinsho Ketsueki; 1975 Jun; 16(6):636-43. PubMed ID: 1057667 [No Abstract] [Full Text] [Related]
8. [A differentiation potency of blasts in chronic myelogenous leukemia in blastic crisis to megakaryocytic lineage]. Sato T, Kanbayashi H, Kawaguchi M, Shiga Y, Abe R, Matsuda S, Uchida T, Kariyone S, Ohto H, Maeda H. Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1360-7. PubMed ID: 3469857 [No Abstract] [Full Text] [Related]
9. [Treatment of myelocytic leukemia during blast transformation (preliminary report)]. Frinovskaia IV, Bogomolova LV. Sov Med; 1976 Aug; (8):28-32. PubMed ID: 1070163 [No Abstract] [Full Text] [Related]
10. Bone-marrow patterns and survival in chronic myeloid leukemia. Bettini R, Ferrari V, Rapazzini P. Haematologica; 1985 Aug; 70(3):272-3. PubMed ID: 3932164 [No Abstract] [Full Text] [Related]
11. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P. Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284 [Abstract] [Full Text] [Related]
12. [Bone-marrow biopsy in chronic myeloid leukemia. Value of the initial examination]. Devred C, Bentata J, Diebold J, Bernadou A, Bilski-Pasquier G. Sem Hop; 1977 Jan 09; 53(2):119-24. PubMed ID: 189424 [Abstract] [Full Text] [Related]